Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
BackgroundEpidermal growth factor (EGF) is implicated in the pathogenesis of schizophrenia, suggesting possible value as a biomarker for disease severity or treatment response. However, basal EGF levels and changes during treatment are inconsistent across studies. The goal of this study is to compar...
Main Authors: | Xiaobin Zhang, Wenhuan Xiao, KuanYu Chen, Yaqin Zhao, Fei Ye, Xiaowei Tang, Xiangdong Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00104/full |
Similar Items
-
Electroconvulsive therapy combined with antipsychotic therapy in the treatment of acute schizophrenia inpatients: symptom profile of the clinical response
by: Derya Ipekcioglu, et al.
Published: (2018-10-01) -
The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function
by: Ying Yang, et al. -
Neuroanatomical Features That Predict Response to Electroconvulsive Therapy Combined With Antipsychotics in Schizophrenia: A Magnetic Resonance Imaging Study Using Radiomics Strategy
by: Yi-Bin Xi, et al.
Published: (2020-05-01) -
Effect of Adjuvant Electroconvulsive Therapy Compared to Antipsychotic Medication Alone on the Brain Metabolites of Patients with Chronic Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study
by: Mehrzad Lotfi, et al.
Published: (2018-06-01) -
Electroconvulsive therapy is associated with lower readmission rates in patients with schizophrenia
by: Yin-bing Ying, et al.
Published: (2021-07-01)